About Sight Sciences, Inc. 
Sight Sciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 23 Schemes (11.1%)
Foreign Institutions
Held by 29 Foreign Institutions (15.81%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
20 Million
(Quarterly Results - Sep 2025)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 337 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.80
-71.72%
5.25






